Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reshape Lifesciences Inc. (ETRM) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Reshape Lifesciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1371217.
Total stock buying since 2014: $660,053.
Total stock sales since 2014: $22,639.
Total stock option exercises since 2014: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2020 | 40,410 | $82,984 | 0 | $0 | 0 | $0 |
2019 | 3,437,525 | $225,046 | 0 | $0 | 0 | $0 |
2017 | 0 | $0 | 25,155 | $22,639 | 0 | $0 |
2016 | 20,000 | $11,000 | 0 | $0 | 0 | $0 |
2015 | 1,447,745 | $320,952 | 0 | $0 | 0 | $0 |
2014 | 11,800 | $20,071 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2020-12 | 6,400 | $13,306 | 0 | $0 | 0 | $0 |
2020-11 | 6,477 | $11,869 | 0 | $0 | 0 | $0 |
2020-09 | 5,930 | $12,669 | 0 | $0 | 0 | $0 |
2020-08 | 14,103 | $27,935 | 0 | $0 | 0 | $0 |
2020-07 | 4,500 | $6,750 | 0 | $0 | 0 | $0 |
2020-01 | 3,000 | $10,455 | 0 | $0 | 0 | $0 |
2019-12 | 19,500 | $50,525 | 0 | $0 | 0 | $0 |
2019-11 | 409,166 | $35,819 | 0 | $0 | 0 | $0 |
2019-09 | 396,072 | $9,901 | 0 | $0 | 0 | $0 |
2019-08 | 603,928 | $28,637 | 0 | $0 | 0 | $0 |
2019-07 | 500,000 | $19,750 | 0 | $0 | 0 | $0 |
2019-02 | 1,192,000 | $0 | 0 | $0 | 0 | $0 |
2019-01 | 316,859 | $80,414 | 0 | $0 | 0 | $0 |
2017-12 | 0 | $0 | 20,487 | $0 | 0 | $0 |
2017-05 | 0 | $0 | 4,668 | $22,639 | 0 | $0 |
2016-06 | 20,000 | $11,000 | 0 | $0 | 0 | $0 |
2015-11 | 1,060,000 | $184,910 | 0 | $0 | 0 | $0 |
2015-08 | 303,000 | $74,772 | 0 | $0 | 0 | $0 |
2015-05 | 84,745 | $61,270 | 0 | $0 | 0 | $0 |
2014-06 | 11,800 | $20,071 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-12-04 | Boyd Steven | Buy | 5,400 | 2.06 | 11,151 |
2020-12-02 | Boyd Steven | Buy | 1,000 | 2.15 | 2,155 |
2020-11-17 | Boyd Steven | Buy | 187 | 2.25 | 420 |
2020-11-13 | Boyd Steven | Buy | 790 | 2.07 | 1,635 |
2020-11-10 | Boyd Steven | Buy | 2,400 | 1.79 | 4,296 |
2020-11-02 | Boyd Steven | Buy | 3,100 | 1.78 | 5,518 |
2020-09-23 | Boyd Steven | Buy | 2,000 | 2.04 | 4,070 |
2020-09-22 | Boyd Steven | Buy | 1,000 | 2.38 | 2,385 |
2020-09-21 | Boyd Steven | Buy | 300 | 2.23 | 667 |
2020-09-18 | Boyd Steven | Buy | 2,000 | 1.89 | 3,770 |
2020-09-16 | Boyd Steven | Buy | 100 | 1.88 | 187 |
2020-09-16 | Stankovich Thomas (Chief Financial Officer) | Buy | 530 | 3.00 | 1,590 |
2020-08-20 | Boyd Steven | Buy | 2,000 | 1.70 | 3,400 |
2020-08-19 | Boyd Steven | Buy | 1,998 | 1.61 | 3,220 |
2020-08-19 | Stankovich Thomas (Chief Financial Officer) | Buy | 4,105 | 3.00 | 12,315 |
2020-08-18 | Boyd Steven | Buy | 6,000 | 1.50 | 9,000 |
2020-07-17 | Boyd Steven | Buy | 4,500 | 1.50 | 6,750 |
2020-01-29 | Boyd Steven | Buy | 3,000 | 3.48 | 10,455 |
2019-12-20 | Boyd Steven | Buy | 3,048 | 2.62 | 8,001 |
2019-12-19 | Boyd Steven | Buy | 9,000 | 2.56 | 23,085 |
2019-12-16 | Boyd Steven | Buy | 3,000 | 2.62 | 7,875 |
2019-12-11 | Boyd Steven | Buy | 452 | 2.73 | 1,231 |
2019-12-09 | Boyd Steven | Buy | 2,071 | 2.58 | 5,332 |
2019-12-06 | Boyd Steven | Buy | 300 | 2.62 | 787 |
2019-12-05 | Boyd Steven | Buy | 1,224 | 2.58 | 3,164 |
2019-12-04 | Boyd Steven | Buy | 405 | 2.60 | 1,050 |
2019-11-26 | Boyd Steven | Buy | 2,000 | 2.71 | 5,430 |
2019-11-22 | Boyd Steven | Buy | 1,495 | 2.62 | 3,909 |
2019-11-20 | Boyd Steven | Buy | 1,300 | 2.71 | 3,516 |
2019-11-18 | Boyd Steven | Buy | 1,535 | 2.98 | 4,574 |
2019-11-14 | Boyd Steven | Buy | 2,200 | 3.67 | 8,085 |
2019-11-12 | Boyd Steven | Buy | 636 | 3.62 | 2,305 |
2019-11-11 | Boyd Steven | Buy | 400,000 | .02 | 8,000 |
2019-09-17 | Boyd Steven | Buy | 396,072 | .03 | 9,901 |
2019-08-30 | Boyd Steven | Buy | 53,928 | .04 | 1,887 |
2019-08-29 | Boyd Steven | Buy | 80,000 | .07 | 5,600 |
2019-08-28 | Boyd Steven | Buy | 100,000 | .07 | 7,000 |
2019-08-27 | Boyd Steven | Buy | 20,000 | .07 | 1,400 |
2019-08-08 | Boyd Steven | Buy | 100,000 | .04 | 4,000 |
2019-08-07 | Boyd Steven | Buy | 250,000 | .04 | 8,750 |
2019-07-26 | Boyd Steven | Buy | 300,000 | .04 | 12,000 |
2019-07-25 | Boyd Steven | Buy | 150,000 | .04 | 6,000 |
2019-07-24 | Boyd Steven | Buy | 50,000 | .04 | 1,750 |
2019-02-01 | Sabby Management, Llc (10% Owner) | Buy | 1,192,000 | .00 | 0 |
2019-01-31 | Sabby Management, Llc (10% Owner) | Buy | 10,301 | .27 | 2,812 |
2019-01-30 | Sabby Management, Llc (10% Owner) | Buy | 48,000 | .28 | 13,440 |
2019-01-29 | Sabby Management, Llc (10% Owner) | Buy | 12,200 | .28 | 3,391 |
2019-01-25 | Sabby Management, Llc (10% Owner) | Buy | 15,595 | .27 | 4,241 |
2019-01-24 | Sabby Management, Llc (10% Owner) | Buy | 6,190 | .26 | 1,578 |
2019-01-22 | Sabby Management, Llc (10% Owner) | Buy | 5,766 | .28 | 1,608 |
2019-01-18 | Sabby Management, Llc (10% Owner) | Buy | 24,334 | .28 | 6,789 |
2019-01-17 | Sabby Management, Llc (10% Owner) | Buy | 52 | .28 | 14 |
2019-01-16 | Sabby Management, Llc (10% Owner) | Buy | 26,661 | .27 | 7,118 |
2019-01-15 | Sabby Management, Llc (10% Owner) | Buy | 167,760 | .23 | 39,423 |
2017-12-19 | Mashaal Michael Y (Director) | Sale | 20,487 | .00 | 0 |
2017-05-25 | Goldfischer Carl | Sale | 4,668 | 4.85 | 22,639 |
2016-06-03 | Delange Peter M. (SVP, Ops & Bus Dev) | Buy | 20,000 | .55 | 11,000 |
2015-11-12 | Knudson Mark B (Chrmn, Pres & CEO) | Buy | 310,000 | .16 | 49,910 |
2015-11-12 | Gladney Dan W (Chief Executive Officer) | Buy | 750,000 | .18 | 135,000 |
2015-08-13 | Knudson Mark B (Chrmn, Pres & CEO) | Buy | 168,000 | .25 | 41,832 |
2015-08-12 | Knudson Mark B (Chrmn, Pres & CEO) | Buy | 135,000 | .24 | 32,940 |
2015-05-16 | Gladney Dan W (Chief Executive Officer) | Buy | 84,745 | .72 | 61,270 |
2014-06-19 | Friedman Cathy (Director) | Buy | 11,800 | 1.70 | 20,071 |
Insider trading activities including stock purchases, stock sales, and option exercises of ETRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Reshape Lifesciences Inc. (symbol ETRM, CIK number 1371217) see the Securities and Exchange Commission (SEC) website.